SCHEMBL14363191

SCHEMBL14363191

Cc1ccc(O)c(C(=O)Nc2cccc(O)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.60
▸ SRC P12931 1/20 0.59
▸ P2RX1 P51575 4/20 0.58
▸ TMPRSS4 Q9NRS4 2/20 0.58
▸ GRM5 P41594 1/20 0.58
▸ PLAU P00749 2/20 0.57
▸ F2 P00734 1/20 0.57
▸ F10 P00742 1/20 0.57
▸ PLAT P00750 1/20 0.57
▸ P2RX4 Q99571 1/20 0.56
▸ P2RX7 Q99572 1/20 0.56
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ ALDH1A1 P00352 3/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ LMNA P02545 2/20 0.54
▸ NLRP3 Q96P20 1/20 0.54
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ HTT P42858 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285639 0.86 TMPRSS4 (0.67) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL14363294 0.84 NPC1 (0.60) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL14363185 0.83 FADS1 (0.67) P2RX1MEN1KMT2AALDH1A1NLRP3
SCHEMBL11761072 0.83 MAPT (0.61) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL14363184 0.83 PLAU (0.69) MAOBP2RX1TMPRSS4GRM5PLAU
SCHEMBL14363179 0.83 PLAU (0.65) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL21021862 0.82 PLAU (0.73) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL14394718 0.82 P2RX1 (0.78) P2RX1TMPRSS4P2RX4P2RX7MEN1
SCHEMBL14363287 0.82 GPR17 (0.63) P2RX1TMPRSS4GRM5PLAUF2
SCHEMBL14363303 0.81 P2RX1 (0.73) P2RX1MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2007-11-29 — — US disclosed
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2007-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 MAOB 682/4885SRC 1231/4885P2RX1 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback